The Pharmacist and Immune Checkpoint Inhibition: Looking to the Future

You are invited to attend a lunch satellite symposium held during the CAPhO Conference 2017
The Pharmacist and Immune
Checkpoint Inhibition:
Looking to the Future
FRIDAY
APRIL 21, 2017
12:15 PM – 1:45 PM
Fairmont Banff Spring Hotel
At a time when new treatment options are becoming available for
the treatment of many cancers, the pharmacist is well placed and
plays an instrumental part in not only recognizing and managing
adverse events but also educating other members of the
interdisciplinary team.
This conference will demonstrate the value of collaboration with
other healthcare professionals while sharing best practices of
communication and management of immune-checkpoint inhibitors
and immuno-related toxicities with patients and care givers.
LEARNING OBJECTIVES
•Summarize the latest practice-changing evidence affecting the treatment of patients with
metastatic melanoma or lung cancer under immunotherapy (monotherapy or combination)
•Discuss the role of pharmacists within an interdisciplinary team in recognizing and managing
immuno-related toxicities
•Review best practices in the effective management of immuno-related AEs
EXPERT PANEL
Scott Edwards, Pharm D, Msc (Oncology)
Clinical oncology pharmacy specialist,
Dr. H. Bliss Murphy Cancer Center
Assistant professor, School of Pharmacy and the Discipline of Oncology,
Faculty of Medicine
Memorial University of Newfoundland
St. John's, Newfoundland
Sean Hopkins, B.S.P.
Interim Operations Director,
Simcoe Muskoka Regional Cancer Program
Pharmacy Manager, Oncology Services and Research,
Manager, Oncology Clinical Trials,
Royal Victoria Regional Health Centre
Barrie, Ontario
This learning activity is sponsored by Merck Canada Inc.